Results 161 to 170 of about 5,854,621 (365)
INOCULATION OF THE HUMAN AND MURINE LEPROSY BACILLUS INTO THE ANTERIOR CHAMBER OF ANIMALS
, 1952 I Fukuda
openalex +2 more sources
ACHONDROPLASIA: ITS OCCURRENCE IN MAN AND IN ANIMALS. [PDF]
, 1906 CharlesR Keyser
openalex +1 more source
Toxoplasma gondii: from animals to humans.
International Journal of Parasitology, 2000 A. Tenter, A. Heckeroth, L. Weiss
semanticscholar +1 more source
Molecular Oncology, EarlyView.This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani +14 more
wiley +1 more source
On the power wisdom and goodness of God as manifested in the creation of animals and in their history habits and instincts. [PDF]
William Kirby
openalex +1 more source
THE EFFECTS OF LIGHTNING ON MEN AND THE LOWER ANIMALS. [PDF]
, 1909 Samuel Wilks
openalex +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
Molecular Oncology, EarlyView.In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
A NEW SYNTHESIS OF TYROSINE FROM ANHYDROUS PRUSSIC ACID AND OXY-BENZALDEHYDE : AN EXPLANATION OF ITS MODE OF FORMATION IN THE ANIMAL BODY. [PDF]
, 1905 Peter Latham
openalex +1 more source
Regulation of microRNA function in animals
Nature reviews. Molecular cell biology, 2018 Luca F. R. Gebert, I. MacRae
semanticscholar +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Molecular Oncology, EarlyView.Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source